Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Adult
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: BTNT (ORPHAcode is broader than the targeted code used
      to represent it)
    Reference: '148000'
    Source: OMIM
  Label: Kaposi sarcoma
  ORPHAcode: '33276'
  ORPHApacketId: '33276'
  PURL: http://www.orpha.net/ORDO/Orphanet_33276
  Parents:
  - Parent:
    - Label: Soft tissue sarcoma
      ORPHAcode: '3394'
  - Parent:
    - Label: Rare vascular tumor
      ORPHAcode: '211237'
  - Parent:
    - Label: Human herpesvirus 8-related disorder
      ORPHAcode: '102024'
  - Parent:
    - Label: Pediatric soft tissue sarcoma
      ORPHAcode: '602681'
  - Parent:
    - Label: Rare virus associated cancer
      ORPHAcode: '602711'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Obligate (100%)
      HPOId: HP:0005353
      HPOTerm: Recurrent herpes
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001034
      HPOTerm: Hypermelanotic macule
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002814
      HPOTerm: Abnormality of the lower limb
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0008069
      HPOTerm: Neoplasm of the skin
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0012733
      HPOTerm: Macule
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000479
      HPOTerm: Abnormal retinal morphology
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001028
      HPOTerm: Hemangioma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001298
      HPOTerm: Encephalopathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001743
      HPOTerm: Abnormality of the spleen
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002721
      HPOTerm: Immunodeficiency
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0005523
      HPOTerm: Lymphoproliferative disorder
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0008940
      HPOTerm: Generalized lymphadenopathy
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0011024
      HPOTerm: Abnormality of the gastrointestinal tract
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0200034
      HPOTerm: Papule
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0200036
      HPOTerm: Skin nodule
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000988
      HPOTerm: Skin rash
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001004
      HPOTerm: Lymphedema
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001392
      HPOTerm: Abnormality of the liver
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001824
      HPOTerm: Weight loss
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001945
      HPOTerm: Fever
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002014
      HPOTerm: Diarrhea
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002088
      HPOTerm: Abnormal lung morphology
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0005293
      HPOTerm: Venous insufficiency
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0011793
      HPOTerm: Neoplasm by anatomical site
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0200035
      HPOTerm: Skin plaque
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Class only
      PrevalenceType: Point prevalence
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Lifetime Prevalence
      Source: 22033323[PMID]_RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Belgium
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Malta
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: RARECARE surveillance of rare cancers in Europe[REG]
      ValMoy: no data
  TextSection:
    Contents: A rare vascular tumor that is characterized by human herpes virus 8
      (HHV-8)-induced endothelial inflammatory neoplasm that develops with various
      clinically distinct settings manifesting mostly as cutaneous lesions or mucosal
      or visceral involvement.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Not applicable
  copyright: Orphanet (c) 2023
  creationDate: '2023-12-06 11:51:54'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
